[
  {
    "ts": null,
    "headline": "Incyte to Present at Upcoming Investor Conferences",
    "summary": "WILMINGTON, Del., February 17, 2026--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of March:",
    "url": "https://finnhub.io/api/news?id=ad351754fdaffcb71e6971d869958f1e2e3c02b79cc95d8f71df9ddc72b3c398",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771333200,
      "headline": "Incyte to Present at Upcoming Investor Conferences",
      "id": 139122476,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "WILMINGTON, Del., February 17, 2026--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of March:",
      "url": "https://finnhub.io/api/news?id=ad351754fdaffcb71e6971d869958f1e2e3c02b79cc95d8f71df9ddc72b3c398"
    }
  },
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From Incyte’s Q4 Earnings Call",
    "summary": "Incyte’s fourth quarter was met with a negative market reaction, despite the company delivering revenue growth above Wall Street expectations. Management attributed this performance to strong commercial execution across its core products, notably Jakafi and Opsalura, as well as significant progress in the late-stage development pipeline. CEO William Meury highlighted that growth was broad-based, with almost every major product contributing, and commercial milestones were achieved across both est",
    "url": "https://finnhub.io/api/news?id=9b9e1dd9af316f72e796092b4c04c70ff7aa30d1eb5fbd81faa20fdef4fca2e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771306342,
      "headline": "The Top 5 Analyst Questions From Incyte’s Q4 Earnings Call",
      "id": 139121413,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Incyte’s fourth quarter was met with a negative market reaction, despite the company delivering revenue growth above Wall Street expectations. Management attributed this performance to strong commercial execution across its core products, notably Jakafi and Opsalura, as well as significant progress in the late-stage development pipeline. CEO William Meury highlighted that growth was broad-based, with almost every major product contributing, and commercial milestones were achieved across both est",
      "url": "https://finnhub.io/api/news?id=9b9e1dd9af316f72e796092b4c04c70ff7aa30d1eb5fbd81faa20fdef4fca2e3"
    }
  }
]